Koşuyolu Heart Journal最新文献

{"title":"The effect of cardiovascular risk factors and coronary atherosclerosis severity on long term graft patency rate in patients underwent coronary artery bypass graft surgery","authors":"K. Memiç Sancar, Y. Tayyareci, N. Yazicioğlu, Bingul Dilekci Sahin, O. Yildiz, S. Yurdakul, C. Ciftci","doi":"10.51645/khj.2021.m50","DOIUrl":"https://doi.org/10.51645/khj.2021.m50","url":null,"abstract":"","PeriodicalId":239985,"journal":{"name":"Koşuyolu Heart Journal","volume":"6 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-04-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"127727494","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"TAPSE/sPAP predicts the long-term prognosis in pulmonary arterial hypertension patients","authors":"B. Uygur, M. Yıldız, A. Demir, S. Kahraman, K. Sancar, Ayfer Utkusavas, H. Ağuş, A. Güner, Özge Çelik, M. Ertürk","doi":"10.51645/khj.2021.m64","DOIUrl":"https://doi.org/10.51645/khj.2021.m64","url":null,"abstract":"Introduction: Pulmonary arterial hypertension (PAH) is a progressive and life-threatening disease in which the risk stratification and the prognostic evaluation play a crucial role. Assessment of RV function is an important part of the follow-up. Tricuspid annular plane systolic excursion to systolic pulmonary artery pressure ratio (TAPSE/sPAP) is a simple, and readily available echocardiographic parameter which was stated as a prognostic predictor in various cardiac diseases. Herein, our aim was to evaluate the role of TAPSE/sPAP in prediction of long-term prognosis in PAH. Patients and Methods: Our retrospective study enrolled a total of 41 PAH patients including 25 idiopathic PAH and 16 congenital heart disease associated PAH patients. Comprehensive echocardiographic examination, laboratory examination, six minutes walking test and cardiopulmonary exercise test were performed to all patients at the same day. Primary endpoint of the study was mortality or hospitalization. The relationship between TAPSE/sPAP and the composite outcomes were evaluated statistically. Results: During mean 20.2 ± 9.2 months follow-up, nine patients were hospitalized, and three patients died. Median TAPSE/sPAP was 0.26 (0.19-0.40). TAPSE/sPAP [p= 0.003; HR (95% CI): 10.928 (2.240-53.316)] was found to be an independent predictor of composite outcomes in PAH patients. TAPSE/sPAP < 0.23 predicted mortality and hospitalization with a sensitivity of 80.0%, specificity of 71.4% [area under curve (AUC): 0.768; 95% CI: 0.596-0.939; p= 0.013]. The Kaplan-Meier cumulative survival curve revealed that as TAPSE/ sPAP decreased, mortality and hospitalization rates increased significantly. Moreover, NT-proBNP [p= 0.014; HR (95% CI): 1.001 (1.000-1.001)] was found to be an independent predictor. Conclusion: TAPSE/sPAP was an independent predictor of long-term prognosis in PAH. TAPSE/sPAP which is a simple, cheap and readily available echocardiographic parameter, might be used as an important prognostic factor in PAH patients.","PeriodicalId":239985,"journal":{"name":"Koşuyolu Heart Journal","volume":"13 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-04-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114794141","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Mitral Annulus Caseous Calcification: Not A Conundrum with Cardiac Computerized Tomography","authors":"Ç. Topel, A. E. Ulutaş, Gamze Babür Güler","doi":"10.51645/KHJ.2021.13","DOIUrl":"https://doi.org/10.51645/KHJ.2021.13","url":null,"abstract":"A 58-year-old woman with atrial fibrillation was referred for mitral valve replacement due to mitral valve mass on echocardiography. Transesophageal and transthoracic echocardiography showed an echogenic, round mass attached to the basal portion of the posterior mitral valve, mild degeneration of both mitral leaflets and moderate mitral regurgitation. Cardiac computerized tomography (CT) was planned to further assess the mass and its relationship with the mitral apparatus. Cardiac CT showed densely calcified caseous thickening of the mitral annulus that was measured 32 x 13 mm and encircling the posterior mitral annulus which protruded towards the posterior leaflet without disruption of the mitral apparatus. The heart team assessed the patient with integrated findings of transesophageal echocardiography and cardiac CT and decided to manage conservatively.","PeriodicalId":239985,"journal":{"name":"Koşuyolu Heart Journal","volume":"13 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"117058367","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Outcomes of Operated Partial-Intermediate Atrioventricular Septal Defect Patients","authors":"Özlem Sarısoy, C. Ayabakan, N. Tokel, M. Özkan, R. Türköz, S. Aşlamacı","doi":"10.51645/KHJ.2021.26","DOIUrl":"https://doi.org/10.51645/KHJ.2021.26","url":null,"abstract":"Introduction: Follow-up results of patients with partial-intermediate atrioventricular septal defect (AVSD) operated in 1996-2016 at Baskent University are presented. Patients and Methods: Data obtained from hospital records consists of echocardiographic and angiographic details before surgery, age and weight at surgery, operative details, presence of Down’s syndrome, details of postoperative care, early postoperative and latest echocardiographic findings and hospitalization for reintervention. Results: One hundred seventy eight patient-files were reviewed including 41.6% (n= 74) male, 58.4% (n= 104) female patients. The mean age of patients were 47.09 ± 44.25 (median, 30; 25 and 75 percentiles, 17 and 66.5, respectively) months. The mean body weight during the operation was 15.00 ± 11.22 (median, 11; 25 and 75 percentiles, 8.27 and 17, respectively) kg. Study group included 152 patients (85.3%) with partial AVSD and 26 of patients (14.7%) with partial AVSD. A total of 39 patients (19.1%) were diagnosed with down syndrome. Associated cardiac anomalies were present in 21.3% of patients. Operative technique was modified single-patch technique (Wilcox) in 14.6% (26 patients), pericardial patch in 25.8% (128 patients) and pericardial patch and annuloplasty in 13.5% (24 patients). The cleft in the left atrioventricular (AV) valve was closed in 92.1% all of patients.The early mortality and morbidity in the postoperative first month were calculated as 5.6 and 21.2% and the late mortality (> 1 month) and morbidity rates were calculated as 1.2% and 17%, respectively. The most common cause of late morbidity was left AV valve insufficiency, left ventricular outflow tract obstruction and therefore reoperations (15.2%). Conclusion: Although the mortality and morbidity rates are low in partial AVSD operations, the rate of reoperations for left AV valve insufficiency and left ventricular outflow tract obstruction are still high. Patients should be done corrective surgery around age two and follow up should be performed in terms of reoperating requirement.","PeriodicalId":239985,"journal":{"name":"Koşuyolu Heart Journal","volume":"253 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"123123131","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Vacuum-Assisted Closure for Sternal Wound Infection After Coronary Artery Bypass Surgery","authors":"H. Erdem, Ayse Karakoc, Seda Karasakal, Yeliz Karacı, A. Antal, H. Sunar","doi":"10.51645/KHJ.2021.35","DOIUrl":"https://doi.org/10.51645/KHJ.2021.35","url":null,"abstract":"Introduction: Vacuum-assisted closure of sternal infected wounds has been reported to improve morbidity and mortality, besides decreasing duration of hospitalization. The aim of this study was to evaluate early outcomes of vacuum-assisted closure of infected sternal wounds after coronary bypass surgery in our clinic. Patients and Methods: Sixty six patients who had sternal wound infection after coronary bypass surgery in our hospital between January 2016 and December 2019 were included in the study. After surgical debridement and removal of foreign materials, vacuum-assisted closure therapy was initiated at a mean postoperative 26.56 ± 5.5 days. After wound healing and negative cultures, treatment was terminated and sternal wounds were closed with appropriate procedures. Results: Fifty six patients (84.84%) had deep sternal infection and 10 patients (15.15%) had superficial sternal infection. Early mortality was 13.63% (nine patients), all having deep sternal infections. The most common microorganisms cultured were Staphylococcus aureus and Pseudomonas aeruginosa. Mean duration of hospitalization was 39.68 ± 2.48 days. No complications related with vacuum-assisted closure were detected. Recurrent sternal wound infection was not observed in any of the surviving patients. Conclusion: Our results confirm that vacuum-assisted closure of wounds is a safe and effective treatment option for patients who are not candidates for primary closure or early muscle flap closure.","PeriodicalId":239985,"journal":{"name":"Koşuyolu Heart Journal","volume":"113 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"124903324","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Initial Experience with Cadaveric Lobar Lung Transplantation in Turkey","authors":"M. Vayvada, A. Erkılınç","doi":"10.51645/KHJ.2021.27","DOIUrl":"https://doi.org/10.51645/KHJ.2021.27","url":null,"abstract":"Introduction: Lung transplantation is the final treatment option for end-stage lung diseases. A scarce donor pool is the primary cause of waiting list mortality. Lobar lung transplantation has been proposed to overcome the donor pool shortage. Herein we present our initial experience with patients who underwent lobar lung transplantation. Patients and Methods: This single-center retrospective study included patients who underwent cadaveric lobar lung transplantation between December 2016 and December 2018 at our Lung Transplant Center. The procedure was performed only in patients with an emergency status. Results: Of the 55 lung transplants during the study period, six [10.9%; four female, two male; median age, 35.3 years (range, 22-42 years)] were lobar lung transplants. The indications were bronchiectasis (three patients), chronic obstructive pulmonary disease (one patient), cystic lung disease (one patient), and lepidic type adenocarcinoma (one patient). The transplantations included bilateral lobar lung in two patients, the right single lung and the left lower lobe in two patients, and the left single lung and the right lower lobe in two patients. One-year mortality was 16.6% (1/6). Two patients died 23 and 24 months after lung transplantation. Three patients were alive at the last follow-up (at 24, 25, 47 months). Conclusion: Lobar lung transplantation can be a life-saving treatment option in critically ill patients with small thoracic cavities to overcome donor shortage. Furthermore, it is a feasible operative technique in recipients with a reduced unilateral thoracic cavity.","PeriodicalId":239985,"journal":{"name":"Koşuyolu Heart Journal","volume":"76 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"132139088","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Does Concomitant Tricuspid Annuloplasty Increase the Need for Permanent Pacemaker Implantation Following Mitral Valve Replacement?","authors":"R. Aksoy, E. Selçuk, A. Küp, D. Çevirme, Üzeyi̇r Yilmaz, Veysel Başar, Furkan Balci, M. Rabus","doi":"10.51645/KHJ.2021.06","DOIUrl":"https://doi.org/10.51645/KHJ.2021.06","url":null,"abstract":"","PeriodicalId":239985,"journal":{"name":"Koşuyolu Heart Journal","volume":"33 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"128738226","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Determination of Predictors of Acute Kidney Injury in Patients with Coronary Bifurcation Lesions Revascularized with the Two-Stent Strategy","authors":"A. Demir, Gokhan Demirci, S. Aslan, B. Uygur, Y. Avcı, A. Kalkan, M. Ertürk","doi":"10.51645/KHJ.2021.29","DOIUrl":"https://doi.org/10.51645/KHJ.2021.29","url":null,"abstract":"Introduction: Acute kidney injury (AKI) is an important complication that increases mortality, morbidity, hospitalization and costs after the invasive cardiac procedures. The incidence of AKI and the factors affecting the development of AKI after the revascularization of coronary bifurcation lesions with the two-stent strategy remain unclear. Patients and Methods: We retrospectively evaluated 230 consecutive non-ST elevation myocardial infarction (NSTEMI) patients who underwent revascularization with the two-stent strategy for the true coronary artery bifurcation lesions between January 2015 and September 2020, and did not meet the exclusion criteria. AKI was defined as meeting Acute Kidney Injury Network (AKIN) group criteria with the development of creatinine changes within the first 48 hours after the procedure. ACEF (age, serum creatinine, left ventricular ejection fraction) score was calculated for all patients. Results: AKI developed in 28 (12.2%) patients after the procedure. As a result of the multivariable analysis, hypertension, ACEF score ≥ 1.14 and contrast agent volume ≥ 252 mL were determined as independent predictors for AKI. The coronary anatomical factors and technique related factors had no effect on AKI development. ACEF score ≥ 1.14 had sensitivity of 82.1%, specificity of 60.9% and negative predictive value of 96.1% for detecting AKI development. Moreover, the rate of AKI in the group with high ACEF score was significantly higher than the group with low ACEF score (22.5% vs. 3.9%, p< 0.001). Conclusion: The simple and extremely user-friendly ACEF score can accurately describe the risk of AKI development after the revascularization of coronary bifurcation lesions with the two-stent strategy.","PeriodicalId":239985,"journal":{"name":"Koşuyolu Heart Journal","volume":"58 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"117061564","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"New Predictors in Determining the Need for Invasive Treatment in NSTEMI During the COVID-19 Pandemic? A Retrospective Study","authors":"E. Aksu, D. Avcı, Enes Çelik, B. Öztürk, M. Bozan, Kemal Göçer, A. Aykan","doi":"10.51645/KHJ.2021.44","DOIUrl":"https://doi.org/10.51645/KHJ.2021.44","url":null,"abstract":"Introduction: The non-invasive approach has become the first choice for the acute non-ST elevation myocardial infarction-acute coronary syndrome (NSTEMI-ACS) during the Coronavirus Disease-2019 (COVID-19) pandemic. However, most of these patients require interventional treatment. In this study, the possible role of hematological inflammatory markers in differentiating medium-high risk NSTEMI-ACS patients according to the GRACE risk classification in need of interventional treatment was investigated. Patients and Methods: Patients who underwent coronary angiography with the diagnosis of NSTEMI-ACS in a tertiary cardiology clinic between January 2018 and December 2019 were included in the study, which was designed as a retrospective cohort study. NSTEMI-ACS patients (n= 276), except for patients with exclusion criteria (n= 32), were divided into two groups as those in need of invasive treatment (n= 217) and medical treatment (n= 59) according to the results of coronary angiography. The hematological inflammatory markers were compared between groups. Results: Neutrophil to lymphocyte ratio (NLR) (AUC: 0.637, 95% CI: 0.563-0.712, p= 0.001) and systemic immune-inflammation index (SII) (AUC: 0.622, 95% CI: 0.545-0.699, p= 0.004) predicted the requirement of interventional treatment in NSTEMI-ACS. Conclusion: It is unclear whether the NLR and SII elevation, which may be a predictor of the need for invasive treatment, is a cause or a consequence of the pathophysiological process in patients with NSTEMI-ACS. However, elevated NLR and SII values can help distinguish NSTEMI-ACS patients who need invasive treatment during the COVID-19 pandemic. The results of this study, show the need for large-sized studies to determine the ideal cut-off point of NLR and SII levels in determining the treatment strategy for NSTEMI-ACS.","PeriodicalId":239985,"journal":{"name":"Koşuyolu Heart Journal","volume":"3 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"116109926","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Renal Artery Embolism: A Salvage Therapy with Catheter-Directed Intra Arterial Ultraslow Thrombolytic Infusion","authors":"S. Uysal, D. Çeneli, Z. Şimşek, E. Alizade","doi":"10.51645/KHJ.2021.07","DOIUrl":"https://doi.org/10.51645/KHJ.2021.07","url":null,"abstract":"Renal artery thrombosis is an uncommon but threatening condition. Although percutaneous interventions and thrombolytic treatments have proven beneficial, there is no clear treatment strategy. We present a patient that was diagnosed with right renal artery thrombosis, and nephrectomy was suggested at the referred hospital. In this case, catheter-directed intra arterial ultraslow thrombolytic infusion secured the patency of the renal artery as a salvage therapy. The aim of this case report is to draw attention to catheter-directed intra arterial thrombolytic infusion in renal artery thrombosis treatment options.","PeriodicalId":239985,"journal":{"name":"Koşuyolu Heart Journal","volume":"28 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"133016939","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}